Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS
about
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assayCommon variants of the vitamin D binding protein gene and adverse health outcomesPathogenesis of human immunodeficiency virus infectionDeclining incidence of AIDS dementia complex after introduction of zidovudine treatmentHuman immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees.Clinical manifestations and the natural history of HIV infection in adultsHuman Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in HarProductive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeysHIV-1 P24 antigenaemia does not predict time of survival in AIDS patientsThe effects of twice and four times daily zidovudine on p24 antigenaemia in CDC stage II/III patientsClinical, virological and immunological features of primary HIV-1 infectionDevelopment and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.Human immunodeficiency virus contains an epitope immunoreactive with thymosin alpha 1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30.Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.HIV-1-specific antibody responses during acute and chronic HIV-1 infectionAlpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment.Correlation of serum antigen and antibody concentration with clinical features in HIV infection.Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.Practical diagnostic testing for human immunodeficiency virus.Antigen detection for human immunodeficiency virus.Markers predicting progression of human immunodeficiency virus-related disease.Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells.The incubation period of Alzheimer's disease and the timing of tau versus amyloid misfolding and spreading within the brain.Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.Linear B-cell epitopes of the major core protein of human immunodeficiency virus types 1 and 2.Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophagesCharacterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides.Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort.Tests for infection with HIV: slandered goods.Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU)Principles of laboratory isolation and identification of the human immunodeficiency virus (HIV).Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.Analysis of antibody responses to phenotypically distinct lentiviruses.
P2860
Q24535105-52854E6F-B126-4BAA-9561-C20868EF8E44Q24596671-D5D2BB61-979A-47C1-87C4-2EBCAF990801Q24634681-A8EEBCD7-78CB-40C5-B7AA-F928D8F08508Q28341520-30054FDD-197C-4574-8882-1CFA160A81CCQ33582665-F3FFB7D6-68AC-48FD-B9EA-B7CCEBCF334EQ33615090-EC1685E5-8443-451A-9F12-68B175AB1B74Q33787448-D129115E-253F-4B32-8B3B-23A016047456Q33811630-931224B9-6142-438A-A310-8A1F9BE3C130Q33903860-9704E339-DB14-4F44-A46D-14C65949A595Q33932589-47EBA010-DE7E-4B33-9C4B-D7D27D49F181Q33932937-6FC5C97C-71FE-48FA-B000-3AAC86CF9D86Q33933276-AE85B477-EB99-4D7C-8707-A8C0FF18B8B3Q34042316-07E8D12E-80F1-4A62-8417-E8EC84D8C2FCQ34619693-0EE1EA22-4D98-4305-BDC1-1833FA1052C8Q34628871-C6CC28A2-1481-42BF-8012-A49852C2AB58Q35096836-02D2B843-5B31-4838-9F13-1EEA732C26C2Q35272996-50917C3A-8147-47B8-BB11-A1AA3A0686B9Q35625556-6C58D6F4-331E-4D3C-A2E1-D907C58F6920Q35626209-A278803B-5110-4EE7-83EC-D9477F7AA638Q35874055-8435A358-0E41-4BA3-884C-46D43F015965Q36531631-DF7B3C87-8547-420B-8AF3-51F7CF8BE7E5Q36632724-28F89D1D-96A7-45D2-ABDD-F88BE61F8C2DQ36635240-80723DA3-07D9-4103-B45F-C133677BF58EQ36640801-FC7E8A55-2F39-4D9A-B010-A9E3B489E8FFQ36647277-21A59AEE-E516-478B-AC48-EECE32715EA4Q36701936-8DF07604-4F12-46FE-8B5E-8E89D51968E2Q36762790-5C0162E3-12A8-4703-9702-8B2840C57997Q36780418-F3B395E7-C74A-4F20-A418-7D28330076B0Q36782827-98FA9875-9F74-424C-AD5F-81D968F5FEFDQ36797335-58222412-4113-4F35-A499-876937922CE3Q36797520-C3F10E01-C98B-451C-97D0-70B1176D186DQ36830029-54908B1B-1CB2-4A36-8626-E8CFCD6C1BC0Q36830799-29F9970D-E9CD-44B7-8E6A-EFCB085B3B0BQ36895162-A316D536-1CB9-49A9-A520-AA03A6CFF30DQ36896797-0C7ED4C2-BA21-4E0A-98C2-A2AAD0AD50F3Q36989554-5C5E07DA-C084-4A33-8093-5D9D672A6CCAQ36989592-0329E921-FE48-4150-84C7-EF0B1AA7F4AEQ37153174-87A5A115-46E5-4653-8B5E-03A54A36E0C9Q37172571-B3F55A03-F243-4FB0-8501-BA5189B063D3Q37181601-072B7CE8-36E1-40DE-945F-448FF198F2B7
P2860
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS
description
1986 nî lūn-bûn
@nan
1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
name
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@ast
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@en
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@nl
type
label
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@ast
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@en
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@nl
prefLabel
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@ast
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@en
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@nl
P2093
P2860
P921
P1433
P1476
Persistent HIV antigenaemia an ...... ciated with transition to AIDS
@en
P2093
Coutinho RA
Goudsmit J
Huisman HG
van den Berg H
van der Noordaa J
P2860
P304
P407
P577
1986-12-01T00:00:00Z